Review
Aug 2026
Recent developments in donepezil-based hybrid molecules as multi-target therapeutics for Alzheimer's disease: A paradigm shift beyond symptomatic treatment.
Rather than presenting DPZ-based hybrids as established disease-modifying therapies, the available evidence supports their role as promising multifunctional lead compounds and valuable molecular platforms for the rational design of next-generation anti-Alzheimer agents.
Nitin Kumar, Izhar Khan, Jyoti Singh et al.
· Bioorganic chemistry (Print) · 1 citation